PWRM, Power3 Medical Products Inc, PWRM.OB
PWRM is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).
PWRM applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, PWRM has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
World wide, breast cancer comprises 10.4% of all the cancer incidence among the ladies, which makes it the most common type of non-skin cancer in females and also the fifth most popular grounds for cancer death. In '04, cancer of the breast induced 519,000 deaths worldwide (7% of cancer deaths; virtually 1% of all deaths). Breast cancers is about a hundred times more widespread in females compared to males, despite the fact that men generally have poorer success as a result of waiting times in medical diagnosis.
Parkinson's disease (PD) is part of a team of ailments known as motor system disorders, which are the result of the loss of dopamine-producing brain cells. The 4 fundamental symptoms of PD are tremor, or moving in hands, arms, legs, jaw, and face; hardness, or perhaps tightness of your limbs and trunk; bradykinesia, or slowness to move; and postural lack of stability, or inable sense of balance and also co-ordination. As far as signs and symptoms, they are more noticable, patients might have trouble walking, talking, or finishing many other very simple tasks.
Alzheimer's has no current cure, nonetheless treatments designed for conditions can be purchased and research continues on. Even though most current Alzheimer treatments can't eliminate Alzheimer's disease from progressing, they're able to temporarily impede the worsening connected with symptoms as well as advance well being for anyone with Alzheimer's not to mention all their caregivers. Today, there exists a world-wide exertion under way to find better ways to take care of the disease, delay its onset, and forestall it from evolving.
PWRM recently reported that it has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc., a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. The company has a robust intellectual property portfolio and has created numerous products for adult stem cell therapy that are ready for market globally.
More about PWRM at www.Power3Medical.com
First Solar, Inc. (Nasdaq:FSLR) recently reported that they have entered into agreements for NextEra Energy Resources to purchase four solar photovoltaic (PV) projects totaling 40 megawatts (MW) in Ontario, Canada from First Solar, Inc. Under the terms of the project agreements, First Solar will continue developing and will construct the Sombra and Moore Solar Energy Centers, using First Solar’s advanced thin film solar modules.
First Solar, Inc. (First Solar) is engaged in the manufacture and sale of solar modules with an advanced thin film semiconductor technology, and it designs, constructs and sells photovoltaic (PV) solar power systems. It operates the business in two segments: components segment and systems segment.
China is the world's biggest producer of rare earth elements, most are used in today's technologies, which include new energy sources and hybrid cars. It announced in July that it will cut exports for minerals used to make hybrid cars and televisions by 72 percent during the 2nd half of the year.
Rare-earth metals include terbium, which finds use in flat-panel TVs and high-efficiency fluorescent lamps, and neodymium, key to the permanent magnets in high-efficiency electric motors. Rare-earth metals are not indeed rare. The series of nonferrous metals is common in the environment. According to Design Chain Associates, most rare-earth metals are as common as copper, and even the rarest is more common than gold.
Part of the market pressure on rare-earth metals comes from new demands that green technologies has prompted. The market, including electric- and hybrid-vehicle motors and wind turbines, requires magnets.
Restrictions on Chinese exports are generating opportunities for non-Chinese projects
AVOT, American Video Teleconferencing Corp., AVOT.PK
AVOT recently reported that it has signed an option agreement to acquire two claim blocks in townships of Mekinac and Lajuene, Province of Quebec. These claim blocks are approximately 3600 acres in total and are located 120 miles east of Montreal P.Q. and 50 miles north of Three Rivers P.Q. They are accessible year round with infrastructure in the immediate vicinity. The claims adjoin a property that had one of the highest readings of Rare Earths in North America. Sampling in the 1950s gave readings of 48% combined Cerium, Lanthanum, Neoymium and Yttrium. That property has remained dormant for over 50 years but the new owners plan an extensive exploration program this fall.
The company, after a lengthy search and after careful due diligence, believes this is going to be one of the most active areas for Rare Earths exploration and our holdings are in the same geological setting as the 48% Rare Earths showing.
AVOT recently has hired a French speaking geologist to search the archives of the Quebec Department of Mines for Rare Earths showings not on a current computer file. AVOT believes the rare earths industry is where it wants to maintain a very strong focus and is looking to expand its holdings.
Mechel OAO (NYSE:MTL), a leading Russian mining and steel group, recently reported that it intends to release its financial results for the nine months ending September 30, 2010, on Tuesday, December 14, 2010.
Mexican airport operator Grupo Aeroportuario del Centro Norte, S.A.B. de C.V., known as OMA (Nasdaq:OMAB), reported that terminal passenger traffic at its 13 airports decreased 0.9% in November 2010, as compared to November 2009. Domestic traffic decreased 2.1%, and international traffic increased 5.3%.
Signup for FREE Daily Stock Alerts From http://www.CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) anticipates to receive 2,000,000 shares of (144) restricted common stock of American Video Teleconferencing Corp. (OTCPK:AVOT) from the company for 12 months IR Services. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).